wasa
Thanks for the kind words.
For what it's worth (and it may be worth very little), I'm thinking that a "short timeframe" could be any time within the next 6 months, given the company's persistent use of tantalising phrase sets such as:being in "advanced discussions with potential licensees of Progenza rights for disease specific indications in Japan" (24/5/17 announcement); and, now having positive clinical data to support "near term Progenza licensing opportunities in Japan"(22/5/17 announcement).
zeno9
wasa Thanks for the kind words. For what it's worth (and it may...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CMB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.996M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 850 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 6419 | 1 |
View Market Depth
| Last trade - 16.12pm 03/09/2024 (20 minute delay) ? |
| CMB (ASX) Chart |
Day chart unavailable